Skip to main content

Table 1 Characteristics of studies included in this meta-analysis

From: Bone mesenchymal stem cell therapy for ovariectomized osteoporotic rats: a systematic review and meta-analysis

Studies

Animals

No. of animals (con/v)

Fracture site

Fracture model

Treatment group

Control group

Treatment duration

Outcomes

Yu, Zr

2012 [15]

SD rats, female, 3-month-old

8/8/8

femur

OVX, fracture

BMSCs, BMSCs+PLGA/COL microspheres

SHAM

3 months

BMD, (BV/TV), (Tb.Sp)

XU ZW

2013 [16]

SD rats, female, (350±8.695)g

18/18/18

tibia

OVX, fracture

BMSCs, BMSCs+Drynaria fortunei extraction

Blank

7/14/28/40 days

BMD

Liu,X

2016 [17]

SD rats, female, (180-220)g

12/12/12

mandibles

OVX, fracture

BMSCs/HA, OPG-BMSCs/HA

HA

4/6/8 weeks

BMD

Li, KC

2016 [18]

SD rats, female, 8-week-old

8/8/6

femur

OVX, fracture

BMSCs, BMSCs+214S

SHAM

2/4 weeks

BMD,(BV/TV),(Tb.Sp)

Xu, RY

2016 [19]

SD rats, female, 3-month-old

5/5

mandibles

OVX, fracture

BMSCs

SHAM

12 weeks

(BV/TV), (Tb.Sp)

  1. Abbreviations: SD Sprague-Dawley, OVX ovariectomy, BMD Bone Mineral Density, BMSCs Bone mesenchymal stem cells